Satsuma Pharmaceuticals, Inc. Operating Lease, Expense
Satsuma Pharmaceuticals, Inc. reported Operating Lease, Expense of $300.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-03-28
- Satsuma Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2021-12-31 was $100.00K.
- Satsuma Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2021-09-30 was $100.00K.
- Satsuma Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2021-06-30 was $100.00K.
- Satsuma Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2021-03-31 was $100.00K.
- Satsuma Pharmaceuticals, Inc. operating lease, expense for fiscal 2021 was $300.00K, a 0.00% change from fiscal 2020.
- Satsuma Pharmaceuticals, Inc. operating lease, expense for fiscal 2020 was $300.00K, a 50.00% increase from fiscal 2019.
- Satsuma Pharmaceuticals, Inc. operating lease, expense for fiscal 2019 was $200.00K, a 100.00% increase from fiscal 2018.
- Satsuma Pharmaceuticals, Inc. operating lease, expense for fiscal 2018 was $100.00K, a 0.00% change from fiscal 2017.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $200.00K derived: sum of 2 quarters · filed 2023-03-28 | $300.00K derived: sum of 3 quarters · filed 2023-03-28 | $300.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-03 | $200.00K derived: sum of 2 quarters · filed 2022-11-03 | $200.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-09 | $100.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $300.00K 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $200.00K 10-K · filed 2021-03-25 | |||
| 2018-12-31 | $100.00K 10-K · filed 2020-03-10 | |||
| 2017-12-31 | $100.00K 10-K · filed 2020-03-10 |